Celldex (NASDAQ: CLDX) reported Q2 EPS of ($0.65), $0.01 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $270 thousand versus the consensus estimate of $528 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.